|

TVB-2640 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Weill Medical College of Cornell University1

Indications

  • Prostatic Neoplasms, Castration-Resistant1
  • Cancer1

New York, New York1 trial

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Weill Cornell Medicine/NewYork-Presbyterian Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.